Remote monitoring of medical device

Details for Australian Patent Application No. 2006213947 (hide)

Owner Covidien AG

Inventors Japuntich, John C.

Agent Spruson & Ferguson

Pub. Number AU-B-2006213947

Priority 11/246901 07.10.05 US

Filing date 13 September 2006

Wipo publication date 26 April 2007

Acceptance publication date 30 April 2009

International Classifications

G06Q 50/00 (2006.01) Systems or methods specially adapted for a specific business sector, e.g. health care, utilities, tourism or legal services

B65F 1/14 (2006.01) Refuse receptacles - Other constructional features

G01F 23/00 (2006.01) Level indicators

G01V 15/00 (2006.01) Tags attached to, or associated with, an object, in order to enable detection of the object

Event Publications

28 September 2006 Complete Application Filed

  Priority application(s): 11/246901 07.10.05 US

26 April 2007 Application Open to Public Inspection

  Published as AU-B-2006213947

27 September 2007 Change of Name(s) of Applicant(s), Section 104

  Sherwood Services AG The name of the applicant has been changed to Covidien AG

30 April 2009 Application Accepted

  Published as AU-B-2006213947

27 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213948-Fresh cheese products containing biogenerated flavor components and methods for producing

2006213946-Variolin derivatives as anti-cancer agents